Real-World Data Show All RA Drug Classes Not Created Equal
(MedPage Today) -- Clear differences were apparent among the three major types of targeted medications for rheumatoid arthritis (RA) in a large European registry study.
For one, patients using inhibitors of the Janus-associated kinase (JAK) pathway...
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news